Home Administrative Billing & Reimbursement Health and Wellness Medical PEAR portal Pharmacy Products Quality Management

​​​Reminder: In-office or Labcorp lead testing is recommended for patients ages 2 and younger

October 26, 2022

​As part of the enhanced lead testing program, AmeriHealth HMO, Inc. and AmeriHealth Insurance Company of New Jersey providers are reminded to promptly administer the lead test to patients ages 2 and younger with no record of a blood lead level test.

  • If you are fully trained and have the supplies to administer a lead test using the filter paper technique, please test eligible patients at their next routine office visit.
  • If your patient has a telemedicine visit, please write a prescription so the patient can have the lead test administered at a local Labcorp, Inc. (Labcorp) patient service center, including Labcorp at Walgreens locations.* Once they have the prescription, the patient's parent or guardian can find a full list of Labcorp locations online and schedule an appointment.

Samples (collected in your office or at any Labcorp patient service center) will be tested at a Labcorp laboratory, with results delivered to you in a few days. Once you receive the results, please follow up with your patients as needed.

For more information on the enhanced lead testing program, contact Joy Binns at 215-241-3941. For questions regarding the filter paper testing technique, contact your Labcorp representative at 1-877-725-7241 or Joe Huffer at hufferj@labcorp.com.

*Use CPT® code 83655 to report the completion of lead testing in the office or at a Labcorp patient service center.

CPT Copyright 2017 American Medical Association. All rights reserved. CPT® is a registered trademark of the American Medical Association.


This content was prepared for the Provider News Center and may not be reproduced in any way without the express written permission of AmeriHealth, AmeriHealth HMO, Inc., AmeriHealth Insurance Company of New Jersey.
© 2023 AmeriHealth Site Map        Anti-Fraud        Privacy Policy        Legal        Disclaimer